,headline,final_score,datetime
10,Here's Why We're Not At All Concerned With Beam Therapeutics' (NASDAQ:BEAM) Cash Burn Situation,86,2023-04-15 05:26:26
15,Beam Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day,86,2023-03-27 04:30:00
16,Bernstein Initiates Coverage of Beam Therapeutics (BEAM) with Market Perform Recommendation,86,2023-03-21 15:44:55
17,"Beam Therapeutics Appoints Gopi Shanker, Ph.D., as Chief Scientific Officer",86,2023-03-21 03:30:00
18,Beam Therapeutics appoints Gopi Shanker as chief scientific officer,86,2023-03-20 22:57:00
19,"Beam Therapeutics names Gopi Shanker, Ph.D., as Chief Scientific Officer",86,2023-03-20 22:35:00
20,Beam Therapeutics initiated with a Market Perform at Bernstein,86,2023-03-20 21:03:00
21,Beam Therapeutics to Participate in the Barclays 2023 Global Healthcare Conference,86,2023-03-15 03:30:00
22,January 2024 Options Now Available For Beam Therapeutics,86,2023-03-13 04:31:00
25,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Owens & Minor (OMI), Invitae (NVTA) and Beam Therapeutics (BEAM)",86,2023-03-06 04:52:00
26,Industry Analysts Just Upgraded Their Beam Therapeutics Inc. (NASDAQ:BEAM) Revenue Forecasts By 17%,90,2023-03-05 04:02:47
